Please login to the form below

Not currently logged in
Email:
Password:

Ibuprofen could reduce Parkinson's risk

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

OTC painkillers such as ibuprofen may reduce the risk of developing Parkinson's disease, according to new research.

Regular use of OTC NSAIDs was associated with a 60 per cent reduction in the risk of developing Parkinson's disease, compared with occasional or non-use.

The study compared the use of aspirin and other NSAIDs in 579 men and women, half of whom had Parkinson's disease. Regular NSAID use was defined as taking two or more tablets a week for at least one month. Regular use of aspirin was associated with a 40 per cent reduction in risk, but only among women.

"Our findings suggest NSAIDs are protective against Parkinson's disease, with a particularly strong effect among regular users of non-aspirin NSAIDs, especially those who reported two or more years of use," commented study author Dr Anelika Wahner of the UCLA School of Public Health in Los Angeles.

The results are published in full in the 6 November 2007 issue of Neurology, the medical journal of the American Academy of Neurology.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...